Trial
NCT00358163
Trial of PTK787/ZK 222584 Plus Paclitaxel
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
Novartis Pharmaceuticals; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Massachusetts General Hospital
Condition
Metastatic Non-hematologic Malignancies
Intervention
PTK787/ZK 222584
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-29